-
Quantum Computing-Enhanced Algorithm Unveils Novel Inhibitors for KRAS
Authors:
Mohammad Ghazi Vakili,
Christoph Gorgulla,
AkshatKumar Nigam,
Dmitry Bezrukov,
Daniel Varoli,
Alex Aliper,
Daniil Polykovsky,
Krishna M. Padmanabha Das,
Jamie Snider,
Anna Lyakisheva,
Ardalan Hosseini Mansob,
Zhong Yao,
Lela Bitar,
Eugene Radchenko,
Xiao Ding,
Jinxin Liu,
Fanye Meng,
Feng Ren,
Yudong Cao,
Igor Stagljar,
Alán Aspuru-Guzik,
Alex Zhavoronkov
Abstract:
The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integr…
▽ More
The discovery of small molecules with therapeutic potential is a long-standing challenge in chemistry and biology. Researchers have increasingly leveraged novel computational techniques to streamline the drug development process to increase hit rates and reduce the costs associated with bringing a drug to market. To this end, we introduce a quantum-classical generative model that seamlessly integrates the computational power of quantum algorithms trained on a 16-qubit IBM quantum computer with the established reliability of classical methods for designing small molecules. Our hybrid generative model was applied to designing new KRAS inhibitors, a crucial target in cancer therapy. We synthesized 15 promising molecules during our investigation and subjected them to experimental testing to assess their ability to engage with the target. Notably, among these candidates, two molecules, ISM061-018-2 and ISM061-22, each featuring unique scaffolds, stood out by demonstrating effective engagement with KRAS. ISM061-018-2 was identified as a broad-spectrum KRAS inhibitor, exhibiting a binding affinity to KRAS-G12D at $1.4 μM$. Concurrently, ISM061-22 exhibited specific mutant selectivity, displaying heightened activity against KRAS G12R and Q61H mutants. To our knowledge, this work shows for the first time the use of a quantum-generative model to yield experimentally confirmed biological hits, showcasing the practical potential of quantum-assisted drug discovery to produce viable therapeutics. Moreover, our findings reveal that the efficacy of distribution learning correlates with the number of qubits utilized, underlining the scalability potential of quantum computing resources. Overall, we anticipate our results to be a stepping stone towards developing more advanced quantum generative models in drug discovery.
△ Less
Submitted 12 February, 2024;
originally announced February 2024.
-
Chemically Motivated Simulation Problems are Efficiently Solvable by a Quantum Computer
Authors:
Philipp Schleich,
Lasse Bjørn Kristensen,
Jorge A. Campos Gonzalez Angulo,
Davide Avagliano,
Mohsen Bagherimehrab,
Abdulrahman Aldossary,
Christoph Gorgulla,
Joe Fitzsimons,
Alán Aspuru-Guzik
Abstract:
Simulating chemical systems is highly sought after and computationally challenging, as the number of degrees of freedom increases exponentially with the size of the system. Quantum computers have been proposed as a computational means to overcome this bottleneck , thanks to their capability of representing this amount of information efficiently. Most efforts so far have been centered around determ…
▽ More
Simulating chemical systems is highly sought after and computationally challenging, as the number of degrees of freedom increases exponentially with the size of the system. Quantum computers have been proposed as a computational means to overcome this bottleneck , thanks to their capability of representing this amount of information efficiently. Most efforts so far have been centered around determining the ground states of chemical systems. However, hardness results and the lack of theoretical guarantees for efficient heuristics for initial-state generation shed doubt on the feasibility. Here, we propose a heuristically guided approach that is based on inherently efficient routines to solve chemical simulation problems, requiring quantum circuits of size scaling polynomially in relevant system parameters. If a set of assumptions can be satisfied, our approach finds good initial states for dynamics simulation by assembling them in a scattering tree. In particular, we investigate a scattering-based state preparation approach within the context of mergo-association. We discuss a variety of quantities of chemical interest that can be measured after the quantum simulation of a process, e.g., a reaction, following its corresponding initial state preparation.
△ Less
Submitted 18 April, 2025; v1 submitted 17 January, 2024;
originally announced January 2024.
-
Recent Developments in Structure-Based Virtual Screening Approaches
Authors:
Christoph Gorgulla
Abstract:
Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year. To solve these problems, new and innovate technologies are needed that make the drug discovery process of small-molecules more time and cost-efficient, and which allow to target…
▽ More
Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year. To solve these problems, new and innovate technologies are needed that make the drug discovery process of small-molecules more time and cost-efficient, and which allow to target previously undruggable target classes such as protein-protein interactions. Structure-based virtual screenings have become a leading contender in this context. In this review, we give an introduction to the foundations of structure-based virtual screenings, and survey their progress in the past few years. We outline key principles, recent success stories, new methods, available software, and promising future research directions. Virtual screenings have an enormous potential for the development of new small-molecule drugs, and are already starting to transform early-stage drug discovery.
△ Less
Submitted 6 November, 2022;
originally announced November 2022.
